Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

News Daily News

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

July 10, 2023

Vast Majority of HFrEF Patients Eligible for Vericiguat

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

February 08, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.